Announcements Trials

Browse Landscape

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Dysplasia 2 Triple Negative Breast Neoplasms 2 Head and Neck Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Prostatic Neoplasms 1 Papillomavirus Infections 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Carcinoma in Situ 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1

Interventions

Sorafenib 52 pembrolizumab 26 Nivolumab 20 Bevacizumab 19 Radiosurgery 17 Doxorubicin 12 atezolizumab 9 Erlotinib Hydrochloride 9 lenvatinib 8 cabozantinib 7 Magnetic Resonance Spectroscopy 7 tremelimumab 6 durvalumab 6 Ramucirumab 6 Radiofrequency Ablation 6 Cisplatin 6 Sunitinib 5 tislelizumab 4 regorafenib 4 Oxaliplatin 4 Leucovorin 4 Ipilimumab 4 Fluorouracil 4 Everolimus 4 Capecitabine 4 nintedanib 3 fluoromisonidazole 3 carotuximab 3 bavituximab 3 Tomography, X-Ray Computed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Hepatocellular × Indomethacin × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡